The WAY Stock Is Trading On Rumors. So Are The Rumors Trading Back.

Waystar Holding (Nasdaq: WAY) is trading at $28.84, up a hair on the day, with a market cap near $5.5 billion and a short float of 12%. That last number is the tell. Roughly one in eight shares out there is short, and this is a company everyone claims to understand and nobody actually agrees on. It's a great place to be, if you like volatility. It's a trap, if you don't.

Let's get the record straight before anyone builds a thesis on the fog.

There is no takeover deal. There is a rumor — Yahoo reported in September that Waystar is weighing a sale that could take it private again, roughly two years after its 2024 IPO, with bankers in early talks. "Weighing" is the operative word. "Early talks" is not "a term sheet." It's a headline, and headlines have a habit of evaporating by the next earnings print. So don't buy WAY as a takeover play. Buy it as a story about whether the business can still grow — and whether the market will pay for that growth at the current price.

Now the business. Q2 of fiscal '26 was genuinely good: revenue of $319.67 million, up 18.1% year over year, beating consensus, with a net margin around 13%. Management guided fiscal '26 revenue to roughly $1.3 billion. That's a reacceleration, not a deceleration, and it matters. Waystar's whole pitch is AltitudeAI, its AI-powered revenue-cycle tooling, which the company says has prevented more than $15.5 billion in denied claims. Whether that marketing number holds up under a skeptical buyer's audit is another matter — but demand for the thing is real, and sticky. Waystar claims roughly 30,000 clients and a big chunk of U.S. patients. Sticky revenue at 18% growth is a nice thing to own.

Here's the problem with a nice thing to own: the price.

At $28.84, Waystar carries a trailing P/E near 41x on that ~$0.70 in trailing EPS, though one tracker reports a trailing P/E of 21.0x for the same EPS. That's not cheap for a payments-and-RCM company, even a fast one. It's a "everything goes right" multiple. The forward P/E of ~15x looks seductive until you remember it's low partly because earnings are currently depressed by a heavy balance sheet — debt-to-equity of 0.37, but with only about $12.6M in cash against roughly $1.48B in debt (Q2'26), the equity is exquisitely sensitive to any EBITDA slip. You don't get to pay a 41x trailing multiple for a balance sheet that amplifies bad news.

And there is bad news to worry about. Not the takeover rumor — the actual stuff:

• Barclays lowered Waystar to Equal Weight (though it raised its target to $30).
• CEO Matthew Hawkins ran a cluster of Rule 10b-1 sales — about $2.2 million on October 6 alone, plus earlier August and September sells. Routine under an auto-plan, sure, but a cluster right before a binary event is the kind of thing that looks worse in hindsight.
• A Kaskela stockholder investigation is open into whether officers or directors breached duties "in connection with recent corporate actions." Fresh, unresolved, and vague enough to keep people up at night.

So you've got growth, a compelling product, a private-buyout rumor keeping bulls caffeinated, a downgrade, insider selling, and a securities investigation. That's not a stock with a clear thesis. That's a stock with five people arguing in the room.

Technically, the picture is honest if not exciting. WAY bottomed near $18 in May, ground its way up a rising channel, and reclaimed the $25.70 base — now real support. It's above its 20-, 50-, and 200-day moving averages, RSI at a constructive-but-not-extended 66, up 7.3% on the week and 12.5% on the month. But there's a ceiling you can feel: the $30 round number and the recent swing high near $30 have acted as a rejection level. It's sitting right under the resistance, of all places.

And then there's the event itself. Waystar's Q3 earnings land November 2, after the close — the company's own press release, which most trackers cite, so treat any calendar listing November 11 as unverified. Consensus is a modest EPS around $0.41 on revenue near $323–324 million. A beat is a catalyst; a mere match is a sell-the-news. Given the short float and the IV baked into a binary print, this is exactly the setup where the crowd that's sure about the direction gets run over by the one it got wrong.

My read? Waystar is a constructive-but-cautious hold. The fundamentals are the strongest pillar and I'll say so: 18% growth, AI demand, sticky clients, high-quality cash flow. But the price has run to meet the bull case, the balance sheet is a lever you don't want in a deceleration, and the governance noise is unresolved. Nothing here is broken. Everything here is fragile at this entry.

So what do you actually do? Buy dips toward the $25.70–$26.50 support, not chases into the $30–$31 zone. Reclaiming and holding $30 is your bull confirmation; a daily close back under $25.70 is your invalidation, and you get out. Size for the earnings gap, don't size against it. The target range off the table is $26 to $30 until the tape tells you otherwise.

Waystar isn't a broken company with a broken story. It's a good company at a demanding price, trading on a rumor about being sold while insiders quietly sell their own shares. In markets like this, the rumor usually outlasts the thesis. Be the one who remembers that.